Patch testing a patient with allergic contact hand dermatitis who is taking infliximab - 24/04/13
Doi : 10.1016/j.jaad.2008.02.016
David Rosmarin, MD a, ⁎ 
, Michelle Bush, MD b, Pamela L. Scheinman, MD b
, Michelle Bush, MD b, Pamela L. Scheinman, MD b a Boston University and Tufts-New England Medical Center Residency Program, Department of Dermatology, Tufts-New England Medical Center, Boston, Massachusetts
b Department of Dermatology, Tufts-New England Medical Center, Boston, Massachusetts
Correspondence to: David Rosmarin, MD, 800 Washington St, Box 114, Boston, MA 02111.Abstract |
We report the case of a patient who developed allergic contact hand dermatitis while receiving infliximab infusions for psoriasis and psoriatic arthritis. Patch testing showed multiple positive allergens. To our knowledge, this is the first case report of successful patch testing in a patient receiving tumor necrosis factor–alpha (TNF-⍺) blockade therapy. TNF-⍺ blockers do not necessarily suppress allergic contact hypersensitivity and are not an absolute contraindication to patch testing.
Le texte complet de cet article est disponible en PDF.Plan
| Funding sources: None. |
|
| Conflicts of interest: None declared. |
|
| Reprints not available from the authors. |
© 2008
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 59 - N° 1
P. 145-147 - juillet 2008 Retour au numéro
Article précédent
- Sarcoidal alopecia as a mimic of discoid lupus erythematosus
- Clifford L. Henderson, Laci Lafleur, Richard D. Sontheimer
- The use of blind skin biopsy in the diagnosis of intravascular B-cell lymphoma
- Elizabeth N. Le, Meg R. Gerstenblith, Allan C. Gelber, Rebecca L. Manno, Padmini D. Ranasinghe, Ronald J. Sweren, Laura Y. McGirt
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?